Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …

In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the end …

Background The impact of COVID-19 on physical and mental health and employment after
hospitalisation with acute disease is not well understood. The aim of this study was to …

The COVID-19 pandemic has led to an unprecedented surge in hospitalised patients with
viral pneumonia. The most severely affected patients are older men, individuals of black and …

Activation of latent TGF-β by the α v β 6 integrin is a critical step in the development of acute
lung injury. However, the mechanism by which α v β 6 -mediated TGF-β activation is …

… Correspondence and requests for reprints should be addressed to R. Gisli Jenkins, MD,
Ph.D., National Institute for Health Research Biomedical Research Centre Nottingham …

Background Idiopathic pulmonary fibrosis, a progressive and inevitably fatal disorder, has a
highly variable clinical course. Biomarkers that reflect disease activity are urgently needed to …

Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis
using animal models, yet few of these compounds have replicated these beneficial effects in …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with
high mortality, uncertain cause, and few treatment options. Studies have identified a significant …

Rationale: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by
scarring of the lung that is believed to result from an atypical response to injury of the …